CA2284127A1 - Flt3 ligand chimeric proteins - Google Patents

Flt3 ligand chimeric proteins Download PDF

Info

Publication number
CA2284127A1
CA2284127A1 CA002284127A CA2284127A CA2284127A1 CA 2284127 A1 CA2284127 A1 CA 2284127A1 CA 002284127 A CA002284127 A CA 002284127A CA 2284127 A CA2284127 A CA 2284127A CA 2284127 A1 CA2284127 A1 CA 2284127A1
Authority
CA
Canada
Prior art keywords
leu
ser
ala
gln
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002284127A
Other languages
English (en)
French (fr)
Inventor
Dennis A. Bennett
Nicholas R. Staten
S. Christopher Bauer
John P. Mckearn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2284127A1 publication Critical patent/CA2284127A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002284127A 1997-04-11 1998-04-10 Flt3 ligand chimeric proteins Abandoned CA2284127A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83702697A 1997-04-11 1997-04-11
US08/837,026 1997-04-11
PCT/US1998/007511 WO1998046750A1 (en) 1997-04-11 1998-04-10 flt3 LIGAND CHIMERIC PROTEINS

Publications (1)

Publication Number Publication Date
CA2284127A1 true CA2284127A1 (en) 1998-10-22

Family

ID=25273300

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002284127A Abandoned CA2284127A1 (en) 1997-04-11 1998-04-10 Flt3 ligand chimeric proteins

Country Status (8)

Country Link
EP (1) EP0973900A1 (pt)
JP (1) JP2001527396A (pt)
AU (1) AU751498B2 (pt)
BR (1) BR9808514A (pt)
CA (1) CA2284127A1 (pt)
NZ (1) NZ337911A (pt)
PL (1) PL336159A1 (pt)
WO (1) WO1998046750A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
JP4444652B2 (ja) 2001-07-11 2010-03-31 マキシゲン・ホールディングズ・リミテッド Ｇ−ｃｓｆ結合体
JP5137821B2 (ja) 2005-06-01 2013-02-06 マキシジェン， インコーポレイテッド Ｐｅｇ化されたｇ−ｃｓｆポリペプチドおよびその製造方法
ES2377660T3 (es) * 2005-10-28 2012-03-29 Mitsubishi Tanabe Pharma Corporation Nuevo péptido que penetra en las células
CN110004105B (zh) * 2018-01-05 2023-09-29 上海普佑生物医药有限公司 一种蛋白在细胞培养中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314644A (en) * 1993-05-24 2000-11-24 Immunex Corp Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
US5525708A (en) * 1994-03-28 1996-06-11 Cytomed, Inc. Covalent dimer of kit ligand
IL129565A0 (en) * 1996-10-25 2000-02-29 Searle & Co Multi-functional chimeric hematopoietic receptor agonists

Also Published As

Publication number Publication date
JP2001527396A (ja) 2001-12-25
NZ337911A (en) 2001-04-27
EP0973900A1 (en) 2000-01-26
WO1998046750A1 (en) 1998-10-22
BR9808514A (pt) 2000-05-23
AU751498B2 (en) 2002-08-15
AU6972198A (en) 1998-11-11
PL336159A1 (en) 2000-06-05

Similar Documents

Publication Publication Date Title
EP0742826B1 (en) Multivariant il-3 hematopoiesis fusion protein
US6440407B1 (en) Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides
US6361977B1 (en) Methods of using multivariant IL-3 hematopoiesis fusion protein
US6436387B1 (en) Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
KR100456212B1 (ko) 다기능성조혈수용체아고니스트
US6730303B1 (en) Fused G-CSF and IL-3 proteins and uses thereof
AU725547B2 (en) Multi-functional chimeric hematopoietic receptor agonists
WO1997012985A9 (en) Multi-functional hematopoietic receptor agonists
US20070081979A1 (en) Multi-functional chimeric hematopoietic receptor agonists
AU751498B2 (en) flt3 ligand chimeric proteins
CA2182474A1 (en) Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
US6413509B1 (en) Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
AU722759B2 (en) Novel C-MPL receptor agonists
CZ346799A3 (cs) Chimérické proteiny jako flt3 ligandy
AU703627B2 (en) Interleuken-3 (IL-3) receptor agonists
US20050059149A1 (en) Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
AU697433C (en) Multivariant IL-3 hematopoiesis fusion protein

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20070410